Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/47723
Title: Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
Authors: Ulutaş, Firdevs
Bozdemir, Aslı
Çelikyürek, Nevzat Atalay
Albayrak Yaşar, Canan
Çobankara, Veli
Keywords: co-morbid disease
cut-off
gout
hyperuricemia
allopurinol
febuxostat
uric acid
adult
age
Article
cardiovascular disease
chronic kidney failure
cohort analysis
comorbidity
controlled study
cross-sectional study
diabetes mellitus
disease association
drug use
female
follow up
gender
gout
human
hyperlipidemia
hypertension
hyperuricemia
major clinical study
male
middle aged
nephrolithiasis
observational study
prediction
receiver operating characteristic
risk factor
sensitivity and specificity
Turk (people)
Turkey (republic)
uric acid blood level
Publisher: Greek Rheumatology Society and Professional Association of Rheumatologists
Abstract: Objective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout. Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ?7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%). Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease. © 2021
URI: https://doi.org/10.31138/mjr.32.3.243
https://hdl.handle.net/11499/47723
ISSN: 2459-3516
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu

Show full item record



CORE Recommender

SCOPUSTM   
Citations

1
checked on Oct 13, 2024

Page view(s)

50
checked on Aug 24, 2024

Download(s)

24
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.